Tissue Viability Nurse

The Tissue Viability Nurse (TVN) will provide a specialist role under the guidance and leadership of the Tissue Viability Matron. They will provide expert advice and clinical input into the prevention of pressure ulcers and the management of complex wounds.

The TVN will support the Tissue Viability Matron in the delivery of education and training of healthcare professionals, including the supervision of clinical practice, and represent the TVN Matron when they are not available.

They will enable hospital-based staff to become safe, clinically competent, evidence-based practitioners in the prevention and management of pressure ulcers and other complex wounds. The TVN will work as part of the multidisciplinary team with the aim of preventing admission, supporting early discharge and providing ongoing support and advice for patients with wounds within the acute setting.

An exciting opportunity has arisen to join the Tissue viability team, working alongside the Tissue Viability Matron. We are looking for an experienced, motivated and forward-thinking Registered Nurse to work with the current TVN team to support and improve the service.

This is a good opportunity to develop your skills in terms of wound care and pressure ulcer prevention. You will have to work autonomously and have an opportunity to develop your profession. The successful candidate will hold the appropriate qualifications to be a current registered practitioner RGN and demonstrate evidence of continuing professional development.

You will be committed to delivering high quality care with a desire to further develop your career within this service. You will need to have very good communication skills, be highly motivated, organised and be able to work using your own initiative.

The Christie is one of Europe's leading cancer centres, looking after more than 64,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 25% patients are referred to us from other parts of the country.

We are the largest radiotherapy provider in the NHS with one in 20 treatments delivered at The Christie. We have up to 15 linear accelerators operating across our network of sites. We operate the largest chemotherapy unit in the UK on our main site and treatments are also provided at 13 other networked sites, and in patients homes. And as a specialist tertiary surgical centre, we focus on rare cancers, complex procedures, and multidisciplinary approaches to cancer surgery, specialising in colorectal, peritoneal, gynaecological, urological and plastic surgery.

We are also an international leader in research, with world first breakthroughs for over 100 years. We have been named by the UK's National Institute for Health Research (NIHR), as one of the best hospitals providing opportunities for patients to participate in clinical research studies, with more than 800 studies open at any time, caring for over 3,000 patients.